MedPath

The Effectiveness of Biomimetic Materials in Preventing Enamel Demineralization During Fixed Orthodontic Treatment

Not Applicable
Active, not recruiting
Conditions
Enamel Hypomineralization, Dental
Interventions
Other: Colgate toothpaste
Combination Product: Curasept Biosmalto Mousse and toothpaste
Registration Number
NCT05940701
Lead Sponsor
University of Baghdad
Brief Summary

This study will be done to evaluate the impact of Biosmalto Impact Action Mousse™ on the development and healing of WSLs in individuals receiving orthodontic treatment.

The control group received a fluoridated toothpaste (Colgate toothpaste). The intervention group received Curasept toothpaste and additionally at each visit a Curasept Biosmalto Mousse was applied on the facial surface of the maxillary and mandibular anterior teeth using a tray.

For each patient recruited, identical toothbrushes and oral care instructions were given. The patients received instructions to brush their teeth for at least two minutes using an up-down motion on their anterior teeth and a circular motion on their posterior teeth at least three times/day.

Detailed Description

This study is a multicenter randomized clinical trial with blinded parallel groups, simple randomization, an equal allocation ratio (1:1), and no stratification.The patients will be initially assessed for eligibility to be included in the study by the investigator.The study was verbally explained to those who fulfilled the inclusion criteria in order to get their first consent for participation. After that, they received the patient information sheet (Appendix), which explained the purpose of the research. The patients were instructed to thoroughly read the informational material at home and tell the researcher of their intention to participate at the next visit. Participants had to either sign the consent form (which was attached to the patient information sheet) or get their parents' permission (if the participant was under the age of 18 years). The investigator provided the patients with further information or reassurance about the trial if needed.

All the participants received a standardized treatment protocol. The patients were treated with straight wire appliance using metal brackets (3BOrtho, China). Initially, teeth polishing was performed with pumice and rubber cup for 10 seconds using a low-speed handpiece, followed by water rinsing and air drying (oil-free air spray for 30 seconds). Bonding technique was performed using 37% phosphoric acid for 30 seconds (Heinig and Hartmann, 2008b), then washed with water for 15-20 seconds, and dried for 10 seconds. A thin coat of primer was applied to the etched surfaces by an applicator and cured for 15 seconds by the LED light-curing unit. The brackets were bonded using similar adhesive (3B Ortho, white glue, China) and checked so that no obvious extra adhesive is remained on the tooth surface around the brackets. The control group received a fluoridated toothpaste (Colgate toothpaste). The intervention group received Curasept toothpaste and additionally at each visit a Curasept Biosmalto Mousse was applied on the facial surface of the maxillary and mandibular anterior teeth using a tray.

For each patient recruited, identical toothbrushes and oral care instructions were given. The patients received instructions to brush their teeth for at least two minutes using an up-down motion on their anterior teeth and a circular motion on their posterior teeth at least three times/day. Additionally, the patients were instructed not to use any additional antimicrobial-containing products (mouthwash, toothpaste, gel).

Recruitment & Eligibility

Status
ACTIVE_NOT_RECRUITING
Sex
All
Target Recruitment
65
Inclusion Criteria
  • Willingness to participate.
  • No underlying medical conditions requiring medications that may cause dryness of the mouth.
  • Fully erupted permanent maxillary and mandibular canines and incisors that have not been restored.
Read More
Exclusion Criteria
  • Receiving professional fluoridation within the last three months.
  • Untreated cavitated lesions or significant restorations on the facial surfaces of study teeth.
  • Labial restoration of any of the study teeth.
  • Missing any of the study teeth.
  • Severely rotated any of the study teeth (limiting the appearance of buccal surfaces).
  • Patients with enamel hypoplasia, dental fluorosis or tetracycline pigmentation.
  • Dental anomalies related to morphology, anatomy, or development.
  • Pregnancy and xerostomia.
  • Heavy smokers.
  • Craniofacial syndromes such as clefts
Read More

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
control groupColgate toothpasteThe control group will receive a fluoridated toothpaste (Colgate toothpaste) and instructed to brush at least three times/day.
intervention groupCurasept Biosmalto Mousse and toothpasteThe intervention group will receive Curasept toothpaste with instructions and additionally at each visit a Curasept Biosmalto Mousse will be applied on the facial surface of the maxillary and mandibular anterior teeth using a tray.
Primary Outcome Measures
NameTimeMethod
WSLs evaluation6 month

To evaluate the number of WSLs on the labial surfaces of maxillary and mandibular anterior teeth using enamel white spot lesion index (WSLI), ICDAS (International caries detection and assessment system) and DIAGNOdent pen scores at each visit and after six months during orthodontic treatment.

Gorelick Index :

0: no WSLs

1. Slight WSLs

2. extended or excessive WSLs

3. WSLs with cavitation

DIAGNOdent pen reading:

0 - 10 Healthy Tooth Structure 11-20 Outer Half Enamel Caries 21-30 Inner Half Enamel Caries 30+ Dentin Caries

Secondary Outcome Measures
NameTimeMethod
amount of plaque and gingival bleeding6 month

To evaluate the amount of plaque and gingival bleeding by using visible plaque index (VPI) gingival bleeding index (GBI) at each visit (4-6 weeks) Visible plaque index (VPI) 0: non-visible plaque 1: visible plaque Gingival bleeding index (GBI) 0: no gingival bleeding

1: gingival bleeding

Trial Locations

Locations (1)

Samar Husam Assim Alkhdhairi

🇮🇶

Baghdad, Iraq

© Copyright 2025. All Rights Reserved by MedPath